Arthrex Plus
Arthrex Plus, licence 80077791: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Les Herbes Pures J.B. Ltée
- NPN or DIN-HM
- 80077791
- Status
- Active licence
- Licence date
- 26 May 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crabes | 300.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes | 300.0 milligramme | Not calculated |
| Harpagophytum procumbens Source : Harpagophytum procumbens - Secondary root tuber Extract : Matériel brut sec Extraction ratio : 8.000:1 Dry plant equivalent : 680 milligramme | 85.0 milligramme | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Extract : Matériel brut sec Extraction ratio : 30.000:1 Dry plant equivalent : 195 milligramme Potency : 40.0 % Boswellic acids | 6.5 milligramme | Not calculated |
| Boswellia serrata Source : Boswellia serrata - Oléorésine (écorce de tronc) Extract : Matériel brut sec Extraction ratio : 30.000:1 Dry plant equivalent : 195 milligramme Potency : 40.0 % Boswellic acids | 6.5 milligramme | Not calculated |
| Uncaria guianensis Source : Écorce âgée | 200.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | minimum: 5.0 Capsule ; maximum: 5.0 Capsule | minimum: 1.0 Jour(s) ; maximum: 1.0 Jour(s) |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding or trying to conceive, do not take this product. Do not use if you are under immunosuppressive therapy, if receiving protein-based medications, taking hormonal contraceptives or under hormone replacement therapy. Do not use if you are suffering from systemic lupus erythematosus or HIV.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, constipation, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you are taking anticoagulant or antihypertensive medications, consult a health care practitioner prior to use. If you suffer from an immune system disorder (e.g. Crohn's disease, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, etc.), cancer, asthma, or have severe allergies, consult with a health care practitioner prior to use.
Source
Official Health Canada record, licence 80077791
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.